Combination therapy versus monotherapy in the treatment of recalcitrant warts: A clinical and immunological study

Treatment of recalcitrant warts represents a continuing therapeutic challenge. Combination therapies can help improve treatment response, decrease adverse effects, and reduce recurrence.

[1]  A. Nofal,et al.  Combined acitretin and Candida antigen versus either agent alone in the treatment of recalcitrant warts , 2018, Journal of the American Academy of Dermatology.

[2]  A. Nofal,et al.  Significance of interferon gamma in the prediction of successful therapy of common warts by intralesional injection of Candida antigen , 2017, International journal of dermatology.

[3]  S. Ghonemy.  Treatment of recalcitrant plantar warts with long-pulsed Nd:YAG laser versus cantharidin–podophylline resin–salicylic acid , 2017, Journal of cosmetic and laser therapy : official publication of the European Society for Laser Dermatology.

[4]  A. Gottlieb,et al.  Acitretin for the treatment of recalcitrant plantar warts. , 2017, Dermatology online journal.

[5]  S. Dogra,et al.  Recalcitrant giant condyloma acuminatum treated successfully with a novel combination of Mycobacterium indicus pranii immunotherapy and acitretin , 2017, International journal of STD & AIDS.

[6]  J. Griffin,et al.  Use of Candida antigen injections for the treatment of verruca vulgaris: A two-year mayo clinic experience , 2016, The Journal of dermatological treatment.

[7]  K. Nouri,et al.  Efficacy of intralesional immunotherapy for the treatment of warts: A review of the literature , 2016, Dermatologic therapy.

[8]  M. Weinstein,et al.  Idiopathic CD4 T-Cell Lymphocytopenia , 2016, Journal of cutaneous medicine and surgery.

[9]  M. El-Samahy,et al.  Evaluation of serum interleukin-12 and interferon-&ggr; in patients with multiple warts treated with intralesional tuberculin injection , 2016 .

[10]  E. Crespo,et al.  Intralesional Candida Antigen Immunotherapy for the Treatment of Recalcitrant and Multiple Warts in Children , 2015 .

[11]  D. Fouad,et al.  Intralesional tuberculin (PPD) versus measles, mumps, rubella (MMR) vaccine in treatment of multiple warts: a comparative clinical and immunological study , 2015, Dermatologic therapy.

[12]  A. Nofal,et al.  Treatment of recalcitrant warts with intralesional measles, mumps, and rubella vaccine: a promising approach , 2015, International journal of dermatology.

[13]  C. Elmets.  Guidelines for the Management of Cutaneous Warts , 2014 .

[14]  D. Buckley,et al.  British Association of Dermatologists' guidelines for the management of cutaneous warts 2014 , 2014, The British journal of dermatology.

[15]  A. Fathy,et al.  Evaluation of IL-12 serum level in patients with recalcitrant multiple common warts, treated by intralesional tuberculin antigen , 2014, The Journal of dermatological treatment.

[16]  S. Li,et al.  Successful treatment of giant condyloma acuminatum with combination retinoid and interferon-γ therapy , 2012, International journal of STD & AIDS.

[17]  S. Georgiou,et al.  Large benign condyloma acuminatum: successful treatment with isotretinoin and interferon alpha. , 2012, Acta dermato-venereologica.

[18]  I. Proietti,et al.  Acitretin in management of diffuse common warts: a case report , 2011, Dermatologic therapy.

[19]  J. Hague,et al.  Use of acitretin in the treatment of resistant viral warts , 2011, The Journal of dermatological treatment.

[20]  F. Kaliyadan,et al.  Rapid response to acitretin, combined with cryotherapy, for extensive and recalcitrant verruca vulgaris on the scalp. , 2011, Indian journal of dermatology, venereology and leprology.

[21]  L. Leung.  Recalcitrant nongenital warts. , 2011, Australian family physician.

[22]  M. Nakagawa,et al.  Phase 1 clinical trial of intralesional injection of Candida antigen for the treatment of warts. , 2010, Archives of dermatology.

[23]  M. Yoon,et al.  A novel mutation of the WAS gene in a patient with Wiskott-Aldrich syndrome presenting with recalcitrant viral warts. , 2010, Journal of dermatological science.

[24]  Tae Jin Kim,et al.  Association Between Serum Cytokine Profiles and Clearance or Persistence of High-Risk Human Papillomavirus Infection: A Prospective Study , 2010, International Journal of Gynecologic Cancer.

[25]  D. K. Krupa Shankar,et al.  Acitretin in the management of recalcitrant warts. , 2008, Indian journal of dermatology, venereology and leprology.

[26]  R. Capizzi,et al.  Use of acitretin in a case of giant common warts in an HIV-infected patient. , 2008, European journal of dermatology : EJD.

[27]  Mandi Maronn,et al.  One‐Year Experience with Candida Antigen Immunotherapy for Warts and Molluscum , 2008, Pediatric dermatology.

[28]  L. Oskam,et al.  Serum levels of interferon‐γ, tumour necrosis factor‐α, soluble interleukin‐6R and soluble cell activation markers for monitoring response to treatment of leprosy reactions , 2007 .

[29]  M. Hatta,et al.  Serum levels of interferon-gamma, tumour necrosis factor-alpha, soluble interleukin-6R and soluble cell activation markers for monitoring response to treatment of leprosy reactions. , 2007, Clinical and experimental immunology.

[30]  Michelle M Lipke,et al.  An armamentarium of wart treatments. , 2006, Clinical medicine & research.

[31]  M. Duvic,et al.  Treatment of cutaneous T‐cell lymphoma with retinoids , 2006, Dermatologic therapy.

[32]  Jun-Mo Yang,et al.  Treatment of extensive and recalcitrant viral warts with acitretin , 2006, International journal of dermatology.

[33]  T. Horn,et al.  Intralesional immunotherapy for genital warts. , 2005, Archives of dermatology.

[34]  Sandra M. Johnson,et al.  Cutaneous warts: an evidence-based approach to therapy. , 2005, American family physician.

[35]  P. Roberson,et al.  Intralesional immunotherapy of warts with mumps, Candida, and Trichophyton skin test antigens: a single-blinded, randomized, and controlled trial. , 2005, Archives of dermatology.

[36]  H. McClean,et al.  A cross-sectional survey of treatment choices for anogenital warts , 2005, International journal of STD & AIDS.

[37]  E. Stathopoulos,et al.  Comparative study of systemic Interferon alfa-2a with oral isotretinoin and oral isotretinoin alone in the treatment of recurrent condylomata accuminata , 2005, Archives of Gynecology and Obstetrics.

[38]  Jianyun Lu,et al.  [Effects of BCG-PSN on serum levels of IL-4 and IL-12 in patients with condyloma acuminatum]. , 2004, Zhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences.

[39]  T. Horn,et al.  Intralesional immunotherapy for warts using a combination of skin test antigens: a safe and effective therapy. , 2004, Journal of drugs in dermatology : JDD.

[40]  Jeung-Hoon Lee,et al.  Multiple and Recalcitrant Warts Treated with Oral Acitretin , 2004 .

[41]  P. Roberson,et al.  Immunotherapy for Recalcitrant Warts in Children Using Intralesional Mumps or Candida Antigens , 2003, Pediatric dermatology.

[42]  U. Wollina.  Er:YAG laser followed by topical podophyllotoxin for hard‐to‐treat palmoplantar warts , 2003, Journal of cosmetic and laser therapy : official publication of the European Society for Laser Dermatology.

[43]  P. Roberson,et al.  Intralesional injection of mumps or Candida skin test antigens: a novel immunotherapy for warts. , 2001, Archives of dermatology.

[44]  J M Plasencia,et al.  Cutaneous warts: diagnosis and treatment. , 2000, Primary care.

[45]  J. Mascaró.  Pathogenesis of acne , 2000 .